Capricor Therapeutics (CAPR) News
NASDAQ: CAPRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
7.83-0.18 (-2.25%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
CAPR news summary
We found 2 recent headlines mentioning Capricor Therapeutics (CAPR): 1 in the past week and 2 in the past 30 days, most often from Nasdaq. For price context, CAPR is down 2.25% at $7.83. The most recent story, "Weekly Buzz: RHHBY, NVS, PFE Win FDA Nod; CRBU Scales Back; PCVX, ABBV Report Positive Trial Data", was published by Nasdaq on Oct 9, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Capricor Therapeutics headlines
- Weekly Buzz: RHHBY, NVS, PFE Win FDA Nod; CRBU Scales Back; PCVX, ABBV Report Positive Trial Data(RTTNews) - This week, biopharmaceutical companies saw a busy week of regulatory decisions, strategic partnerships and clinical developments, alongside pipeline setbacks and workforce reductions.NasdaqABBV, ALVO, ARGX, BBIO
- Pre-Market Most Active for Sep 30, 2026 : CAPR, SOFI, NOK, TQQQ, TSLL, SQQQ, SNAP, IBIT, NKE, NIO, ORCL, SGOVThe NASDAQ 100 Pre-Market Indicator is up 110.77 to 30,450.1. The total Pre-Market volume is currently 145,772,447 shares traded.The following are the most active stocks for the pre-market session:…NasdaqCAPR, SOFI, NOK, TQQQ